Protecting patients from infections and antibiotic resistance at Duke-UNC care centers
Official title: CK20-004, Duke-UNC Prevention Epicenter Program for Protecting Patients from Infections, Antibiotics Resistance and Other Adverse Events
Funded at Duke University · NIH-11549948 · Data updated 2026-11-12
A program at Duke-UNC aims to reduce infections and antibiotic resistance among patients by implementing coordinated prevention and safety practices.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | June 1, 2021 |
| Project end | May 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $590,489 |
| NIH project number | 6U54CK000616-05M002 |
| Project ID | NIH-11549948 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients receiving care at Duke University and UNC facilities may be eligible to participate through prevention initiatives and data collection.
✕Less likely to help
Patients not exposed to the specific prevention interventions or whose care settings do not adopt the program may not experience direct benefits.
What this research studies
This grant supports a multi-institution effort to prevent infections and adverse events related to antibiotics in patient care. It will involve teams from Duke and UNC working together to implement proven prevention strategies, track outcomes, and share lessons learned. The goal is to keep patients safer by reducing infections and complications from antibiotic use. Participants may contribute data from their care to improve infection prevention, under careful privacy protections.
Why it matters
Potential benefit: If successful, patients could experience fewer infections and fewer antibiotic-related problems during and after treatment.
How similar studies have gone: Previous hospital-based prevention programs have reduced infection rates and antibiotic-related complications in some settings, supporting the potential for impact.
Where this research is happening
-
Duke University
Durham, United States Active
Researchers
- Principal investigator: Anderson, Deverick John — Duke University
- Study coordinator: Anderson, Deverick John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.